Gerd Zettlmeissl

Gerd Zettlmeissl has been CEO of the Austrian biotechnology company Intercell since autumn 2005 .

After five years of research at the University of Regensburg and the Pasteur Institute , he joined Behringwerke AG in Marburg in 1985 . From 1994 to 1996 he headed the vaccines department there . After the US biotechnology company Chiron Corporation bought the vaccines division of Behringwerke in 1996 , Zettlmeissl became international head of the Industry and Quality department of "Chiron Vaccines" and in 2000 became General Director of Chiron Behring GmbH & Co., the German subsidiary of Chirons.

In 2001 he was appointed to the Intercell Board of Directors as Chief Operating Officer .